On August 3, 2009, the US Food and Drug Administration (FDA) approved pitavastatin (Livalo), making it the eighth statin approved for use in the United States and seventh currently available for sale. This approval comes almost a quarter century after that for the first member of the class, lovastatin, 8 years after generic lovastatin was approved and 4 years after 2 additional statins, pravastatin and simvastatin, lost patent protection and generic versions of them entered the market.
Gagne JJ, Choudhry NK. How Many “Me-Too” Drugs Is Too Many?. JAMA. 2011;305(7):711–712. doi:10.1001/jama.2011.152
Customize your JAMA Network experience by selecting one or more topics from the list below.